ORAL-CONTRACEPTIVES, INSULIN RESISTANCE AND ISCHEMIC VASCULAR-DISEASE

被引：7

作者：

ESCHWEGE, E

FONTBONNE, A

SIMON, D

THIBULT, N

BALKAU, B

SAINTPAUL, M

GARNIER, P

SENAN, C

PAPOZ, L

机构：

[1] ACT SOCIALE ENFANCE & SANTE, CTR PREVENT TELECOMMUN & DIRECT, PARIS, FRANCE

[2] INSERM, U91, F-94010 CRETEIL, FRANCE

[3] FDN RECH HORMONOL, F-94260 FRESNES, FRANCE

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 1990年 / 31卷 / 03期

关键词：

Epidemiology; Glucose tolerance; Oral contraceptives; Plasma insulin; Serum triglycerides; Vascular risk;

D O I：

10.1016/0020-7292(90)91021-H

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

From a large prospective study on diabetes risks, 1112 professionally active, non-menopausal, non-pregnant, healthy women were cross-sectionally analysed according to their use of oral contraception. After adjustment for age, weight and diabetes risk factors, those taking the pill, compared to those who did not, had significantly higher fasting serum insulin, triglycerides and 2-h 75 g OGTT blood glucose levels. The insulin-resistance markers which have recently been cited as ischemic vascular disease risk factors should be carefully monitored in pill users. © 1990.

引用

页码：263 / 269

页数：7

共 45 条

[1]

ALLAIN CC, 1974, CLIN CHEM, V20, P470

[2]

ARMITAGE P, 1980, STATISTICAL METHODS, P289

[3] EFFECT OF VARIOUS CONTRACEPTIVE HORMONAL THERAPIES IN WOMEN WITH NORMAL AND DIABETIC ORAL GLUCOSE-TOLERANCE TEST [J].